Precision BioSciences Inc (DTIL) stock
DTILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends May 21
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 4/3060% above fair value
$7.10+0.05 (+0.71%)
Close on Nov 18, 2026Market cap $195.97MP/E –Yield –
Precision BioSciences price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Precision BioSciences's price to sales ratio was 5.4× on Nov 11, 2026, against 94.2× a year earlier. Over the last 5 years it ranged from 0.4× to 94.2×, with a median of 2.1×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 5.4× | −66.6 |
| 2025 | Dec 31, 2025 | 72.0× | +71.6 |
| 2024 | Dec 31, 2024 | 0.4× | −0.4 |
| 2023 | Dec 29, 2023 | 0.8× | −5.5 |
| 2022 | Dec 30, 2022 | 6.3× | +2.6 |
| 2021 | Dec 31, 2021 | 3.8× | −16.2 |
| 2020 | Dec 31, 2020 | 19.9× | −14.1 |
| 2019 | Dec 31, 2019 | 34.1× | – |
See a number that looks wrong?